IC
SPPI

Ikarian Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Ikarian Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-176,980
Closed -$133K – 164
2023
Q1 		$133K Hold
176,980
– – 0.03% 110
2022
Q4 		$65.2K Hold
176,980
– – 0.02% 79
2022
Q3 		$76K Buy
+176,980
New +$174K 0.02% 100

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NYLIM
New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ikarian Capital's SPPI Position: Q2 2023 in Review

Ikarian Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2023, closing a stake of 176,980 shares — an estimated $133K sold.

Ikarian Capital first reported a position in SPPI in Q3 2022 and held it in 3 quarters. The position peaked at $133K in Q1 2023. 78 funds tracked by Wall St. Rank hold SPPI as of Q2 2023.

  • Ikarian Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2023 after selling out during the quarter.
  • Ikarian Capital sold 176,980 Spectrum Pharmaceuticals Inc shares in Q2 2023, an estimated $133K.
  • Ikarian Capital first reported a position in Spectrum Pharmaceuticals Inc in Q3 2022 and held it in 3 quarters.
  • Ikarian Capital's Spectrum Pharmaceuticals Inc position peaked at $133K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2023.

Based on Ikarian Capital's 13F filing for Q2 2023, filed 14 Aug 2023.